Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-00-001832
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
16
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 GENTA INCORPORATED 10-K 380023
2 CERTIFICATE OF AMENDMENT EX-3.(I)3 5177
3 AMENDED CERTIFICATE OF DESIGNATION EX-3.(I)4 77516
4 CERTIFICATE OF INCREASE OF PREFERRED STOCK EX-3.(I)5 2594
5 RESTATED CERTIFICATE OF INCORPORATION EX-3.(I)8 8926
6 WARRANT AGREEMENT (DECEMBER 23, 1999) EX-10.62 85576
7 WARRANT AGREEMENT (DECEMBER 23, 1999) EX-10.67 83785
8 EMPLOYMENT AGREEMENT (DR. KEN KASSES) EX-10.68 19780
9 1998 STOCK INCENTIVE PLAN EX-10.69 3921
10 EMPLOYMENT AGREEMENT EX-10.70 47675
11 STOCK OPTION AGREEMENT EX-10.71 29021
12 LETTER AGREEMENT FROM SKYEPHARMA PLC EX-10.72 7690
13 CONSENT OF DELOITTE AND TOUCHE LLP EX-23.1 773
14 CONSENT OF DELOITTE EXPERTA LTD EX-23.2 1025
15 CONSENT OF ERNST & YOUNG EX-23.3 643
16 FINANCIAL DATA SCHEDULE EX-27.1 3257
  Complete submission text file 0000950135-00-001832.txt   760494
Mailing Address 99 HAYDEN AVE SUITE 200 LEXINGTON MA 02421
Business Address 99 HAYDEN AVE SUITE 200 LEXINGTON MA 02421 7818605150
GENTA INCORPORATED /DE/ (Filer) CIK: 0000880643 (see all company filings)

EIN.: 330326866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19635 | Film No.: 586204
SIC: 2836 Biological Products, (No Diagnostic Substances)